PVP Ventures Acquires Rs 1.27 Billion Stake in 7Med

29 Aug 2025 CW Team

The transaction, valued at Rs 1.27 billion, involves a mix of primary and secondary stake purchases. This investment aligns with PVP's ambition to build a new-age global healthcare services platform focused on illness, wellness, and care.

Founded by leading nephrology and urology specialists, 7Med operates 22 dialysis centres—both standalone and within hospitals—across six Indian states. It also runs four super-speciality hospitals with a focus on renal care. The company, headquartered in Delhi NCR, employs over 450 professionals and has conducted over one million dialysis procedures to date.

7Med reported an EBITDA of approximately Rs 100 million for FY25, and with PVP’s infusion, aims to scale this to Rs 500 million over the next four years. Expansion plans include broadening its presence in Tier 2 and Tier 3 cities and significantly upgrading local healthcare infrastructure.

Mr Gaurav Davda, Head of M&A and Strategy at PVP, emphasised that the acquisition marks a pivotal step in creating a trusted healthcare brand network tailored to emerging markets. Dr Vijay Kher, Chairman of Epitome Hospitals, added that the partnership would enhance operational efficiency and accelerate access to quality kidney care across geographies.

PVP Ventures, traditionally rooted in real estate, is now actively diversifying through acquisitions. It has partnered with Brigade Enterprises and Casagrand to monetise legacy real estate assets, expecting over Rs 20 billion in cash flows over the next six years, which will be channelled into its healthcare ambitions.

With this deal, PVP Ventures positions itself as a major player in India’s healthcare transformation, targeting both impact and scale in a rapidly growing sector.

PVP Ventures Limited has announced the acquisition of a significant stake in 7Med India Pvt Ltd and Epitome Group of Hospitals, marking a strategic expansion into the healthcare sector. The Board has approved the purchase of an initial 41.2 per cent stake, with a clear roadmap to majority ownership within 12 months and an eventual increase to 76 per cent.The transaction, valued at Rs 1.27 billion, involves a mix of primary and secondary stake purchases. This investment aligns with PVP's ambition to build a new-age global healthcare services platform focused on illness, wellness, and care.Founded by leading nephrology and urology specialists, 7Med operates 22 dialysis centres—both standalone and within hospitals—across six Indian states. It also runs four super-speciality hospitals with a focus on renal care. The company, headquartered in Delhi NCR, employs over 450 professionals and has conducted over one million dialysis procedures to date.7Med reported an EBITDA of approximately Rs 100 million for FY25, and with PVP’s infusion, aims to scale this to Rs 500 million over the next four years. Expansion plans include broadening its presence in Tier 2 and Tier 3 cities and significantly upgrading local healthcare infrastructure.Mr Gaurav Davda, Head of M&A and Strategy at PVP, emphasised that the acquisition marks a pivotal step in creating a trusted healthcare brand network tailored to emerging markets. Dr Vijay Kher, Chairman of Epitome Hospitals, added that the partnership would enhance operational efficiency and accelerate access to quality kidney care across geographies.PVP Ventures, traditionally rooted in real estate, is now actively diversifying through acquisitions. It has partnered with Brigade Enterprises and Casagrand to monetise legacy real estate assets, expecting over Rs 20 billion in cash flows over the next six years, which will be channelled into its healthcare ambitions.With this deal, PVP Ventures positions itself as a major player in India’s healthcare transformation, targeting both impact and scale in a rapidly growing sector.

Infrastructure Urban

09 Jan 2026

Mount Invests Rs 250 Cr, Adds PUF & PEB Plants, 400+ Jobs

TUMKUR, Karnataka, January 8, 2025 - Mount Roofing & Structures Private Limited, one of India's fastest-growing manufacturers in PUF and a leading solutions provider across Pre-Engineered Building (PEB) and Polycarbonate sheets, simultaneously inaugurated its second fully automated continuous Sandwich Panel manufacturing line and a new PEB manufacturing plant at its integrated campus in Tumkur." The milestone expansion, part of a total investment of INR 250 crores, marks a significant advancement in the company's commitment to engineered performance, manu..

Infrastructure Urban

09 Jan 2026

Titan Intech Strengthens UltraLED Push With Global LED Veteran

Titan Intech has announced the induction of global LED industry veteran Su Piow Ko to its Board of Directors, marking a strategic step in strengthening its UltraLED Displays roadmap and building globally competitive LED display solutions from India.The appointment aligns with Titan Intech’s ambition to position India as a hub for advanced, high-quality LED display manufacturing. With an increased focus on UltraLED Displays, the company aims to enhance technical governance, raise manufacturing standards and expand its presence across global markets.Su Piow Ko brings over three decades of inte..

Infrastructure Urban

09 Jan 2026

Dun & Bradstreet Flags New Growth Engines in India 2026 Outlook

Dun & Bradstreet has released its India 2026: D&B’s Perspective report, projecting a stable macroeconomic environment underpinned by fresh opportunities for productivity-led and inclusive growth. The report outlines how India’s next growth phase will be driven by digitised logistics, trusted data ecosystems, clean energy and rising city vitality.According to the outlook, India’s GDP growth is expected to reach around 6.6 per cent by FY2027, supported by resilient consumer demand and sustained public investment. Manufacturing is seen entering a new phase, moving beyond scale towar..